Vaxart IncCompany Details

Get alertedif Vaxart Inc gets funded!
United States
San Francisco
Detailed industries:biotechnology
Company description

Vaxart has developed a platform technology that will let almost any vaccine be delivered orally. Our initial applications include Avian Influenza, annual influenza, second-generation oral versions of existing vaccines, and unmet needs. The company is currently testing an avian flu vaccine in animal models and is working toward a clinical trial in 2010. [company description from]


Funding history

DateDeal sizeInvestors 
January 8th, 2015$18,400,000-View Deal
August 5th, 2013$19,999,997-View Deal
June 29th, 2012$16,868,419-View Deal
January 14th, 2010$3,496,108-View Deal
Create alert
Want to know when Vaxart Inc gets funded?
Key people
John CornwellExecutive_Officer, VPN&COO
Michael FinneyDirector, Executive_Officer
Wouter LatourCEO and Director , Director, Executive Officer, Executive_Officer
Jan LeschlyDirector
David LiebowitzExecutive_Officer
David MaddenExecutive Officer, Executive_Officer
Richard MarkhamDirector
Sean TuckerDirector, Executive Officer, Executive_Officer, Founder, Chief Scientific Officer
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!